Hope for advanced amyloidosis: new drug trial targets survival
Disease control
Terminated
This study tested whether adding the drug birtamimab to standard care helps people with advanced AL amyloidosis live longer. It included 208 adults newly diagnosed with Mayo Stage IV disease, which affects the heart. The trial was stopped early, so results are limited.
Phase: PHASE3 • Sponsor: Prothena Biosciences Ltd. • Aim: Disease control
Last updated May 26, 2026 12:02 UTC